Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Mass spectrometry based metabolomics in chemical and nanomaterial risk assessment In this webinar, Mark Viant, Professor of Metabolomics at the University of Birmingham, will introduce the concepts of metabolomics as well as the challenges faced in chemical hazard assessment.
New Metabolomics Biomarker for Heart Failure Philipp Schatz, Metanomics Health GmbH, speaking at Diagnostics & Biomarkers 2015.
LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
Recent Foodomic Developments to Investigate the Bioactivity of Dietary Ingredients Alejandro Cifuentes, Institute of Food Science Research, speaking at Food Analysis Congress.
Diagnosis of Disorders Affecting Steroid Synthesis and Metabolism by Mass Spectrometry Josep Marcos del Aguila, IMIM, speaking at Clinical Applications of Mass Spectrometry 2014.
Combining Computational Biology and High Content Imaging Approaches for Understanding DNA Damage and Repair Thierry Dorval, AstraZeneca, speaking at High Content Analysis 2014
Insights from Metabolomics in Compartmented Cells Ralf Takors, University of Stuttgart, speaking at Advances in Cellular Assays & Cell Culture 2014
Advances in Volatile Analyses for Disease Diagnosis Norman Ratcliffe, University of the West of England, speaking at Advances in Biodetection & Biosensors 2014.
Biomarker Development to Improve Trials for Type 1 Diabetes Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.